RedHill Biopharma Ltd. (RDHL) stock
RDHLNasdaqPharmaceutical Preparations
$0.35−0.01 (-2.91%)
Close on Nov 17, 2026Market cap $1.78MP/E –Yield –
RedHill Biopharma pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
RedHill Biopharma's pe ratio was 0.0× on Feb 28, 2025, against 2.4× a year earlier. Over the last 2 years it ranged from 0.0× to 4.9×, with a median of 2.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Feb 28, 2025 | 0.0× | −0.0 |
| 2024 | Dec 31, 2024 | 0.1× | −2.4 |
| 2020 | Feb 28, 2020 | 2.4× | −1.1 |
| 2019 | Dec 31, 2019 | 3.6× | – |
See a number that looks wrong?